Live Chat ×
Skip to main content

Lenalidomide in MDS: Where Have We Been and Where Are We Going?

Interview with Dr. Ari Giagounidis from the Marien Hospital in Germany - Recorded 3/24/12
Questions answered include:

  1. What is lenalidomide (also known as Revlimid)?
  2. Is lenalidomide considered for treating patients with other sub-types of MDS besides 5q-minus?
  3. What should patients expect when they begin treatment with lenalidomide?
  4. Is there a limit to how long a patient can be treated with lenalidomide?
  5. Is lenalidomide used in combination with other FDA-approved treatment such as azacitibine (or Vidaza) or decatibine (or Dacogen)?